nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNH5—peripheral nervous system—amyotrophic lateral sclerosis	0.0208	0.0464	CbGeAlD
Dalfampridine—KCNC1—nerve—amyotrophic lateral sclerosis	0.00915	0.0204	CbGeAlD
Dalfampridine—KCNC3—hindbrain—amyotrophic lateral sclerosis	0.00806	0.018	CbGeAlD
Dalfampridine—KCNA2—hindbrain—amyotrophic lateral sclerosis	0.00746	0.0166	CbGeAlD
Dalfampridine—KCND1—hindbrain—amyotrophic lateral sclerosis	0.00713	0.0159	CbGeAlD
Dalfampridine—KCNC1—hindbrain—amyotrophic lateral sclerosis	0.00685	0.0153	CbGeAlD
Dalfampridine—KCNH1—embryo—amyotrophic lateral sclerosis	0.00602	0.0134	CbGeAlD
Dalfampridine—KCNA1—nerve—amyotrophic lateral sclerosis	0.00546	0.0122	CbGeAlD
Dalfampridine—KCND2—hindbrain—amyotrophic lateral sclerosis	0.00466	0.0104	CbGeAlD
Dalfampridine—KCNC3—brainstem—amyotrophic lateral sclerosis	0.00462	0.0103	CbGeAlD
Dalfampridine—KCNA10—nervous system—amyotrophic lateral sclerosis	0.00448	0.00999	CbGeAlD
Dalfampridine—KCND1—embryo—amyotrophic lateral sclerosis	0.00446	0.00994	CbGeAlD
Dalfampridine—KCNA2—brainstem—amyotrophic lateral sclerosis	0.00428	0.00953	CbGeAlD
Dalfampridine—KCNG2—cerebellum—amyotrophic lateral sclerosis	0.00422	0.0094	CbGeAlD
Dalfampridine—KCND1—brainstem—amyotrophic lateral sclerosis	0.00409	0.00911	CbGeAlD
Dalfampridine—KCNA1—hindbrain—amyotrophic lateral sclerosis	0.00409	0.00911	CbGeAlD
Dalfampridine—KCND3—hindbrain—amyotrophic lateral sclerosis	0.00407	0.00906	CbGeAlD
Dalfampridine—KCNB2—nervous system—amyotrophic lateral sclerosis	0.004	0.0089	CbGeAlD
Dalfampridine—KCNH4—nervous system—amyotrophic lateral sclerosis	0.004	0.0089	CbGeAlD
Dalfampridine—KCNG4—nervous system—amyotrophic lateral sclerosis	0.004	0.0089	CbGeAlD
Dalfampridine—KCNC1—brainstem—amyotrophic lateral sclerosis	0.00393	0.00875	CbGeAlD
Dalfampridine—KCNG4—central nervous system—amyotrophic lateral sclerosis	0.00385	0.00857	CbGeAlD
Dalfampridine—KCNH4—central nervous system—amyotrophic lateral sclerosis	0.00385	0.00857	CbGeAlD
Dalfampridine—KCNB2—central nervous system—amyotrophic lateral sclerosis	0.00385	0.00857	CbGeAlD
Dalfampridine—KCNH5—nervous system—amyotrophic lateral sclerosis	0.00365	0.00814	CbGeAlD
Dalfampridine—KCNH5—central nervous system—amyotrophic lateral sclerosis	0.00352	0.00784	CbGeAlD
Dalfampridine—KCNH3—medulla oblongata—amyotrophic lateral sclerosis	0.00343	0.00764	CbGeAlD
Dalfampridine—KCNG2—brain—amyotrophic lateral sclerosis	0.00343	0.00764	CbGeAlD
Dalfampridine—KCNS2—nervous system—amyotrophic lateral sclerosis	0.0034	0.00757	CbGeAlD
Dalfampridine—KCNA6—nervous system—amyotrophic lateral sclerosis	0.0034	0.00757	CbGeAlD
Dalfampridine—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00337	0.0427	CcSEcCtD
Dalfampridine—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00337	0.0427	CcSEcCtD
Dalfampridine—KCNH8—medulla oblongata—amyotrophic lateral sclerosis	0.00332	0.0074	CbGeAlD
Dalfampridine—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00328	0.0415	CcSEcCtD
Dalfampridine—KCNA6—central nervous system—amyotrophic lateral sclerosis	0.00327	0.00729	CbGeAlD
Dalfampridine—KCNS2—central nervous system—amyotrophic lateral sclerosis	0.00327	0.00729	CbGeAlD
Dalfampridine—KCNV1—nervous system—amyotrophic lateral sclerosis	0.00319	0.00712	CbGeAlD
Dalfampridine—KCNA4—medulla oblongata—amyotrophic lateral sclerosis	0.00313	0.00698	CbGeAlD
Dalfampridine—KCNV1—central nervous system—amyotrophic lateral sclerosis	0.00308	0.00685	CbGeAlD
Dalfampridine—KCNH3—spinal cord—amyotrophic lateral sclerosis	0.00306	0.00681	CbGeAlD
Dalfampridine—KCNH4—brain—amyotrophic lateral sclerosis	0.00305	0.00681	CbGeAlD
Dalfampridine—KCNG4—brain—amyotrophic lateral sclerosis	0.00305	0.00681	CbGeAlD
Dalfampridine—KCNB2—brain—amyotrophic lateral sclerosis	0.00305	0.00681	CbGeAlD
Dalfampridine—KCNV2—nervous system—amyotrophic lateral sclerosis	0.00303	0.00675	CbGeAlD
Dalfampridine—KCNS1—medulla oblongata—amyotrophic lateral sclerosis	0.00298	0.00664	CbGeAlD
Dalfampridine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00297	0.0376	CcSEcCtD
Dalfampridine—KCNH8—spinal cord—amyotrophic lateral sclerosis	0.00296	0.00659	CbGeAlD
Dalfampridine—KCNV2—central nervous system—amyotrophic lateral sclerosis	0.00292	0.0065	CbGeAlD
Dalfampridine—KCNG3—nervous system—amyotrophic lateral sclerosis	0.00289	0.00644	CbGeAlD
Dalfampridine—KCNH1—nervous system—amyotrophic lateral sclerosis	0.00289	0.00644	CbGeAlD
Dalfampridine—KCNC2—nervous system—amyotrophic lateral sclerosis	0.00289	0.00644	CbGeAlD
Dalfampridine—KCNC4—medulla oblongata—amyotrophic lateral sclerosis	0.00285	0.00635	CbGeAlD
Dalfampridine—KCNQ2—brainstem—amyotrophic lateral sclerosis	0.00282	0.00629	CbGeAlD
Dalfampridine—KCNA3—spinal cord—amyotrophic lateral sclerosis	0.00279	0.00623	CbGeAlD
Dalfampridine—KCNH5—brain—amyotrophic lateral sclerosis	0.00279	0.00622	CbGeAlD
Dalfampridine—KCNG3—central nervous system—amyotrophic lateral sclerosis	0.00278	0.0062	CbGeAlD
Dalfampridine—KCNC2—central nervous system—amyotrophic lateral sclerosis	0.00278	0.0062	CbGeAlD
Dalfampridine—KCNH1—central nervous system—amyotrophic lateral sclerosis	0.00278	0.0062	CbGeAlD
Dalfampridine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00275	0.0347	CcSEcCtD
Dalfampridine—KCNC1—medulla oblongata—amyotrophic lateral sclerosis	0.00274	0.0061	CbGeAlD
Dalfampridine—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00273	0.0346	CcSEcCtD
Dalfampridine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00273	0.0345	CcSEcCtD
Dalfampridine—KCNH1—cerebellum—amyotrophic lateral sclerosis	0.00272	0.00606	CbGeAlD
Dalfampridine—KCND2—brainstem—amyotrophic lateral sclerosis	0.00267	0.00596	CbGeAlD
Dalfampridine—KCNA2—spinal cord—amyotrophic lateral sclerosis	0.00266	0.00592	CbGeAlD
Dalfampridine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00265	0.0335	CcSEcCtD
Dalfampridine—KCNS2—brain—amyotrophic lateral sclerosis	0.0026	0.00579	CbGeAlD
Dalfampridine—KCNA6—brain—amyotrophic lateral sclerosis	0.0026	0.00579	CbGeAlD
Dalfampridine—KCNH3—nervous system—amyotrophic lateral sclerosis	0.00257	0.00574	CbGeAlD
Dalfampridine—KCNG1—nervous system—amyotrophic lateral sclerosis	0.00257	0.00574	CbGeAlD
Dalfampridine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00255	0.0322	CcSEcCtD
Dalfampridine—KCNH8—nervous system—amyotrophic lateral sclerosis	0.00249	0.00556	CbGeAlD
Dalfampridine—KCNB1—nervous system—amyotrophic lateral sclerosis	0.00249	0.00556	CbGeAlD
Dalfampridine—KCNG1—central nervous system—amyotrophic lateral sclerosis	0.00248	0.00552	CbGeAlD
Dalfampridine—KCNH3—central nervous system—amyotrophic lateral sclerosis	0.00248	0.00552	CbGeAlD
Dalfampridine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00247	0.0312	CcSEcCtD
Dalfampridine—KCNC1—spinal cord—amyotrophic lateral sclerosis	0.00244	0.00544	CbGeAlD
Dalfampridine—KCNF1—medulla oblongata—amyotrophic lateral sclerosis	0.00244	0.00544	CbGeAlD
Dalfampridine—KCNV1—brain—amyotrophic lateral sclerosis	0.00244	0.00544	CbGeAlD
Dalfampridine—KCNH3—cerebellum—amyotrophic lateral sclerosis	0.00242	0.0054	CbGeAlD
Dalfampridine—KCNG1—cerebellum—amyotrophic lateral sclerosis	0.00242	0.0054	CbGeAlD
Dalfampridine—KCNC3—nervous system—amyotrophic lateral sclerosis	0.00242	0.00539	CbGeAlD
Dalfampridine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00241	0.0305	CcSEcCtD
Dalfampridine—KCNH8—central nervous system—amyotrophic lateral sclerosis	0.0024	0.00535	CbGeAlD
Dalfampridine—KCNB1—central nervous system—amyotrophic lateral sclerosis	0.0024	0.00535	CbGeAlD
Dalfampridine—KCNA4—nervous system—amyotrophic lateral sclerosis	0.00235	0.00525	CbGeAlD
Dalfampridine—KCNA3—nervous system—amyotrophic lateral sclerosis	0.00235	0.00525	CbGeAlD
Dalfampridine—KCNH8—cerebellum—amyotrophic lateral sclerosis	0.00235	0.00523	CbGeAlD
Dalfampridine—KCNA1—brainstem—amyotrophic lateral sclerosis	0.00234	0.00522	CbGeAlD
Dalfampridine—KCNC3—central nervous system—amyotrophic lateral sclerosis	0.00233	0.00519	CbGeAlD
Dalfampridine—KCND3—brainstem—amyotrophic lateral sclerosis	0.00233	0.00519	CbGeAlD
Dalfampridine—KCNV2—brain—amyotrophic lateral sclerosis	0.00231	0.00516	CbGeAlD
Dalfampridine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00228	0.0289	CcSEcCtD
Dalfampridine—KCNC3—cerebellum—amyotrophic lateral sclerosis	0.00228	0.00508	CbGeAlD
Dalfampridine—KCNA3—central nervous system—amyotrophic lateral sclerosis	0.00227	0.00505	CbGeAlD
Dalfampridine—KCNA4—central nervous system—amyotrophic lateral sclerosis	0.00227	0.00505	CbGeAlD
Dalfampridine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00224	0.0284	CcSEcCtD
Dalfampridine—KCNA2—nervous system—amyotrophic lateral sclerosis	0.00224	0.00499	CbGeAlD
Dalfampridine—KCNS1—nervous system—amyotrophic lateral sclerosis	0.00224	0.00499	CbGeAlD
Dalfampridine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00224	0.0283	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00223	0.0282	CcSEcCtD
Dalfampridine—KCNA3—cerebellum—amyotrophic lateral sclerosis	0.00222	0.00494	CbGeAlD
Dalfampridine—KCNA4—cerebellum—amyotrophic lateral sclerosis	0.00222	0.00494	CbGeAlD
Dalfampridine—KCNC2—brain—amyotrophic lateral sclerosis	0.00221	0.00492	CbGeAlD
Dalfampridine—KCNH1—brain—amyotrophic lateral sclerosis	0.00221	0.00492	CbGeAlD
Dalfampridine—KCNG3—brain—amyotrophic lateral sclerosis	0.00221	0.00492	CbGeAlD
Dalfampridine—KCNA5—medulla oblongata—amyotrophic lateral sclerosis	0.00218	0.00487	CbGeAlD
Dalfampridine—KCNF1—spinal cord—amyotrophic lateral sclerosis	0.00218	0.00485	CbGeAlD
Dalfampridine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00217	0.0274	CcSEcCtD
Dalfampridine—KCNA2—central nervous system—amyotrophic lateral sclerosis	0.00216	0.00481	CbGeAlD
Dalfampridine—KCNS1—central nervous system—amyotrophic lateral sclerosis	0.00216	0.00481	CbGeAlD
Dalfampridine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00215	0.0272	CcSEcCtD
Dalfampridine—KCNC4—nervous system—amyotrophic lateral sclerosis	0.00214	0.00477	CbGeAlD
Dalfampridine—KCND1—nervous system—amyotrophic lateral sclerosis	0.00214	0.00477	CbGeAlD
Dalfampridine—KCNS3—medulla oblongata—amyotrophic lateral sclerosis	0.00214	0.00477	CbGeAlD
Dalfampridine—KCNQ3—medulla oblongata—amyotrophic lateral sclerosis	0.00214	0.00477	CbGeAlD
Dalfampridine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00214	0.027	CcSEcCtD
Dalfampridine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00211	0.0267	CcSEcCtD
Dalfampridine—KCNA2—cerebellum—amyotrophic lateral sclerosis	0.00211	0.0047	CbGeAlD
Dalfampridine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00209	0.0264	CcSEcCtD
Dalfampridine—KCNC4—central nervous system—amyotrophic lateral sclerosis	0.00206	0.0046	CbGeAlD
Dalfampridine—KCND1—central nervous system—amyotrophic lateral sclerosis	0.00206	0.0046	CbGeAlD
Dalfampridine—KCNH7—nervous system—amyotrophic lateral sclerosis	0.00206	0.00459	CbGeAlD
Dalfampridine—KCNC1—nervous system—amyotrophic lateral sclerosis	0.00206	0.00459	CbGeAlD
Dalfampridine—KCND1—cerebellum—amyotrophic lateral sclerosis	0.00202	0.00449	CbGeAlD
Dalfampridine—KCNC4—cerebellum—amyotrophic lateral sclerosis	0.00202	0.00449	CbGeAlD
Dalfampridine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00201	0.0254	CcSEcCtD
Dalfampridine—KCNQ5—nervous system—amyotrophic lateral sclerosis	0.002	0.00446	CbGeAlD
Dalfampridine—KCNH7—central nervous system—amyotrophic lateral sclerosis	0.00198	0.00442	CbGeAlD
Dalfampridine—KCNC1—central nervous system—amyotrophic lateral sclerosis	0.00198	0.00442	CbGeAlD
Dalfampridine—KCNG1—brain—amyotrophic lateral sclerosis	0.00197	0.00439	CbGeAlD
Dalfampridine—KCNH3—brain—amyotrophic lateral sclerosis	0.00197	0.00439	CbGeAlD
Dalfampridine—KCNA5—spinal cord—amyotrophic lateral sclerosis	0.00195	0.00434	CbGeAlD
Dalfampridine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00194	0.0246	CcSEcCtD
Dalfampridine—KCNH7—cerebellum—amyotrophic lateral sclerosis	0.00194	0.00432	CbGeAlD
Dalfampridine—KCNQ4—cerebellum—amyotrophic lateral sclerosis	0.00194	0.00432	CbGeAlD
Dalfampridine—KCNC1—cerebellum—amyotrophic lateral sclerosis	0.00194	0.00432	CbGeAlD
Dalfampridine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00193	0.0244	CcSEcCtD
Dalfampridine—KCNQ5—central nervous system—amyotrophic lateral sclerosis	0.00193	0.0043	CbGeAlD
Dalfampridine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00192	0.0243	CcSEcCtD
Dalfampridine—KCNS3—spinal cord—amyotrophic lateral sclerosis	0.00191	0.00425	CbGeAlD
Dalfampridine—KCNB1—brain—amyotrophic lateral sclerosis	0.00191	0.00425	CbGeAlD
Dalfampridine—KCNH8—brain—amyotrophic lateral sclerosis	0.00191	0.00425	CbGeAlD
Dalfampridine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00189	0.0239	CcSEcCtD
Dalfampridine—KCND2—medulla oblongata—amyotrophic lateral sclerosis	0.00186	0.00415	CbGeAlD
Dalfampridine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00186	0.0235	CcSEcCtD
Dalfampridine—KCNC3—brain—amyotrophic lateral sclerosis	0.00185	0.00412	CbGeAlD
Dalfampridine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00184	0.0233	CcSEcCtD
Dalfampridine—KCNF1—nervous system—amyotrophic lateral sclerosis	0.00183	0.00409	CbGeAlD
Dalfampridine—KCNA3—brain—amyotrophic lateral sclerosis	0.0018	0.00401	CbGeAlD
Dalfampridine—KCNA4—brain—amyotrophic lateral sclerosis	0.0018	0.00401	CbGeAlD
Dalfampridine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00177	0.0224	CcSEcCtD
Dalfampridine—KCNF1—central nervous system—amyotrophic lateral sclerosis	0.00177	0.00394	CbGeAlD
Dalfampridine—KCNF1—cerebellum—amyotrophic lateral sclerosis	0.00173	0.00385	CbGeAlD
Dalfampridine—KCNS1—brain—amyotrophic lateral sclerosis	0.00171	0.00382	CbGeAlD
Dalfampridine—KCNA2—brain—amyotrophic lateral sclerosis	0.00171	0.00382	CbGeAlD
Dalfampridine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0216	CcSEcCtD
Dalfampridine—KCND2—spinal cord—amyotrophic lateral sclerosis	0.00166	0.0037	CbGeAlD
Dalfampridine—KCNA5—nervous system—amyotrophic lateral sclerosis	0.00164	0.00366	CbGeAlD
Dalfampridine—KCND1—brain—amyotrophic lateral sclerosis	0.00164	0.00365	CbGeAlD
Dalfampridine—KCNC4—brain—amyotrophic lateral sclerosis	0.00164	0.00365	CbGeAlD
Dalfampridine—KCNQ3—nervous system—amyotrophic lateral sclerosis	0.00161	0.00358	CbGeAlD
Dalfampridine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00158	0.02	CcSEcCtD
Dalfampridine—KCNA5—central nervous system—amyotrophic lateral sclerosis	0.00158	0.00352	CbGeAlD
Dalfampridine—KCNQ1—medulla oblongata—amyotrophic lateral sclerosis	0.00157	0.00351	CbGeAlD
Dalfampridine—KCNH7—brain—amyotrophic lateral sclerosis	0.00157	0.00351	CbGeAlD
Dalfampridine—KCNQ4—brain—amyotrophic lateral sclerosis	0.00157	0.00351	CbGeAlD
Dalfampridine—KCNC1—brain—amyotrophic lateral sclerosis	0.00157	0.00351	CbGeAlD
Dalfampridine—KCNQ3—central nervous system—amyotrophic lateral sclerosis	0.00155	0.00345	CbGeAlD
Dalfampridine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00154	0.0195	CcSEcCtD
Dalfampridine—KCNQ5—brain—amyotrophic lateral sclerosis	0.00153	0.00341	CbGeAlD
Dalfampridine—KCNQ3—cerebellum—amyotrophic lateral sclerosis	0.00151	0.00337	CbGeAlD
Dalfampridine—KCNQ2—nervous system—amyotrophic lateral sclerosis	0.00148	0.0033	CbGeAlD
Dalfampridine—KCNH6—nervous system—amyotrophic lateral sclerosis	0.00147	0.00327	CbGeAlD
Dalfampridine—KCNA1—spinal cord—amyotrophic lateral sclerosis	0.00146	0.00325	CbGeAlD
Dalfampridine—KCNQ2—central nervous system—amyotrophic lateral sclerosis	0.00142	0.00317	CbGeAlD
Dalfampridine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00142	0.018	CcSEcCtD
Dalfampridine—KCNH6—central nervous system—amyotrophic lateral sclerosis	0.00141	0.00315	CbGeAlD
Dalfampridine—KCNF1—brain—amyotrophic lateral sclerosis	0.0014	0.00312	CbGeAlD
Dalfampridine—KCND2—nervous system—amyotrophic lateral sclerosis	0.0014	0.00312	CbGeAlD
Dalfampridine—KCNQ2—cerebellum—amyotrophic lateral sclerosis	0.00139	0.0031	CbGeAlD
Dalfampridine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00137	0.0173	CcSEcCtD
Dalfampridine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00136	0.0172	CcSEcCtD
Dalfampridine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00135	0.0171	CcSEcCtD
Dalfampridine—KCND2—central nervous system—amyotrophic lateral sclerosis	0.00135	0.003	CbGeAlD
Dalfampridine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00135	0.017	CcSEcCtD
Dalfampridine—KCND2—cerebellum—amyotrophic lateral sclerosis	0.00132	0.00294	CbGeAlD
Dalfampridine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00128	0.0162	CcSEcCtD
Dalfampridine—KCNA5—brain—amyotrophic lateral sclerosis	0.00125	0.0028	CbGeAlD
Dalfampridine—KCNS3—brain—amyotrophic lateral sclerosis	0.00123	0.00274	CbGeAlD
Dalfampridine—KCNQ3—brain—amyotrophic lateral sclerosis	0.00123	0.00274	CbGeAlD
Dalfampridine—KCNA1—nervous system—amyotrophic lateral sclerosis	0.00123	0.00273	CbGeAlD
Dalfampridine—KCND3—nervous system—amyotrophic lateral sclerosis	0.00122	0.00272	CbGeAlD
Dalfampridine—KCNA1—central nervous system—amyotrophic lateral sclerosis	0.00118	0.00263	CbGeAlD
Dalfampridine—KCND3—central nervous system—amyotrophic lateral sclerosis	0.00118	0.00262	CbGeAlD
Dalfampridine—KCNC1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00245	CbGpPWpGaD
Dalfampridine—KCNA1—cerebellum—amyotrophic lateral sclerosis	0.00115	0.00257	CbGeAlD
Dalfampridine—KCND3—cerebellum—amyotrophic lateral sclerosis	0.00115	0.00256	CbGeAlD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00114	0.00241	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00114	0.00241	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00114	0.00241	CbGpPWpGaD
Dalfampridine—KCNQ2—brain—amyotrophic lateral sclerosis	0.00113	0.00252	CbGeAlD
Dalfampridine—KCNH6—brain—amyotrophic lateral sclerosis	0.00112	0.0025	CbGeAlD
Dalfampridine—KCNA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00111	0.00235	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00109	0.00231	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00109	0.00231	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00109	0.00231	CbGpPWpGaD
Dalfampridine—KCND2—brain—amyotrophic lateral sclerosis	0.00107	0.00239	CbGeAlD
Dalfampridine—KCND3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00106	0.00224	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00106	0.00224	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00106	0.00224	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00219	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00101	0.00213	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00101	0.00213	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00101	0.00213	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000986	0.00209	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000986	0.00209	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000986	0.00209	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000986	0.00209	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000978	0.00207	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000971	0.00206	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000971	0.00206	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000971	0.00206	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000953	0.00202	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000945	0.002	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000945	0.002	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000945	0.002	CbGpPWpGaD
Dalfampridine—KCNA1—brain—amyotrophic lateral sclerosis	0.000938	0.00209	CbGeAlD
Dalfampridine—KCND3—brain—amyotrophic lateral sclerosis	0.000933	0.00208	CbGeAlD
Dalfampridine—KCNH6—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000927	0.00196	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000921	0.00195	CbGpPWpGaD
Dalfampridine—KCNA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000921	0.00195	CbGpPWpGaD
Dalfampridine—KCNA3—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000907	0.00192	CbGpPWpGaD
Dalfampridine—KCNQ1—brain—amyotrophic lateral sclerosis	0.000904	0.00201	CbGeAlD
Dalfampridine—KCNS3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000888	0.00188	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000888	0.00188	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000888	0.00188	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000878	0.00186	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000878	0.00186	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000872	0.00185	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000872	0.00185	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000864	0.00183	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000855	0.00181	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000842	0.00178	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000842	0.00178	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000842	0.00178	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000838	0.00177	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000826	0.00175	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000826	0.00175	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000826	0.00175	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000826	0.00175	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000826	0.00175	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000826	0.00175	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000826	0.00175	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000826	0.00175	CbGpPWpGaD
Dalfampridine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000818	0.00173	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000803	0.0017	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000803	0.0017	CbGpPWpGaD
Dalfampridine—KCNH2—Potassium Channels—KCNJ10—amyotrophic lateral sclerosis	0.000801	0.0017	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000786	0.00166	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000783	0.00166	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000783	0.00166	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000773	0.00164	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00077	0.00163	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00077	0.00163	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000762	0.00161	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000755	0.0016	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000747	0.00158	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000736	0.00156	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000736	0.00156	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000736	0.00156	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000736	0.00156	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000716	0.00152	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000716	0.00152	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000716	0.00152	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000716	0.00152	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000716	0.00152	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000702	0.00149	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000702	0.00149	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000702	0.00149	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000702	0.00149	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000698	0.00148	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000687	0.00145	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000683	0.00145	CbGpPWpGaD
Dalfampridine—CYP2E1—Vitamin A and Carotenoid Metabolism—RARA—amyotrophic lateral sclerosis	0.000678	0.00143	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000673	0.00143	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.000655	0.00139	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000648	0.00137	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000648	0.00137	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000638	0.00135	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000638	0.00135	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000635	0.00134	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000635	0.00134	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000626	0.00133	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000626	0.00133	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000626	0.00133	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000626	0.00133	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000626	0.00133	CbGpPWpGaD
Dalfampridine—KCNH2—medulla oblongata—amyotrophic lateral sclerosis	0.0006	0.00134	CbGeAlD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00059	0.00125	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000572	0.00121	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000572	0.00121	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000566	0.0012	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000558	0.00118	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.000538	0.00114	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.000538	0.00114	CbGpPWpGaD
Dalfampridine—KCNH2—spinal cord—amyotrophic lateral sclerosis	0.000535	0.00119	CbGeAlD
Dalfampridine—KCNQ2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000532	0.00113	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000532	0.00113	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000532	0.00113	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000532	0.00113	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000501	0.00106	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000501	0.00106	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000501	0.00106	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000501	0.00106	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000501	0.00106	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000501	0.00106	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000475	0.00101	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000475	0.00101	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000474	0.001	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000474	0.001	CbGpPWpGaD
Dalfampridine—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000462	0.00103	CbGeAlD
Dalfampridine—KCNG2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000458	0.00097	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000458	0.00097	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000458	0.00097	CbGpPWpGaD
Dalfampridine—KCNA3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000453	0.00096	CbGpPWpGaD
Dalfampridine—KCNH2—nervous system—amyotrophic lateral sclerosis	0.000451	0.001	CbGeAlD
Dalfampridine—KCNB1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000434	0.00092	CbGpPWpGaD
Dalfampridine—KCNH2—central nervous system—amyotrophic lateral sclerosis	0.000434	0.000967	CbGeAlD
Dalfampridine—KCNS3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000426	0.000902	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000426	0.000902	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000426	0.000902	CbGpPWpGaD
Dalfampridine—KCNH2—cerebellum—amyotrophic lateral sclerosis	0.000424	0.000945	CbGeAlD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000422	0.000894	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000422	0.000894	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000422	0.000894	CbGpPWpGaD
Dalfampridine—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000412	0.000918	CbGeAlD
Dalfampridine—KCNB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000404	0.000855	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.0004	0.000848	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.0004	0.000848	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.0004	0.000848	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000384	0.000813	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000384	0.000813	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00038	0.000804	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000362	0.000767	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000362	0.000767	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—DAO—amyotrophic lateral sclerosis	0.000362	0.000767	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00035	0.000741	CbGpPWpGaD
Dalfampridine—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000347	0.000774	CbGeAlD
Dalfampridine—KCNH2—brain—amyotrophic lateral sclerosis	0.000345	0.000768	CbGeAlD
Dalfampridine—KCNB1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000343	0.000727	CbGpPWpGaD
Dalfampridine—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000334	0.000745	CbGeAlD
Dalfampridine—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000327	0.000728	CbGeAlD
Dalfampridine—KCNH2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000323	0.000683	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000312	0.00066	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000295	0.000624	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000285	0.000604	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000274	0.000581	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000274	0.000581	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000274	0.000581	CbGpPWpGaD
Dalfampridine—CYP2E1—brain—amyotrophic lateral sclerosis	0.000265	0.000591	CbGeAlD
Dalfampridine—KCNH2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000265	0.000561	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000265	0.000561	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00026	0.000551	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSR—amyotrophic lateral sclerosis	0.000253	0.000536	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000253	0.000536	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000253	0.000536	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.00025	0.00053	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSR—amyotrophic lateral sclerosis	0.00024	0.000508	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000236	0.0005	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000218	0.000462	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000212	0.000449	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000208	0.00044	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000208	0.00044	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000208	0.00044	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000197	0.000418	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000154	0.000327	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000135	0.000286	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP9—amyotrophic lateral sclerosis	0.000115	0.000244	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP9—amyotrophic lateral sclerosis	0.000115	0.000244	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000112	0.000237	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000112	0.000237	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000112	0.000237	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000109	0.000231	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000106	0.000224	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—amyotrophic lateral sclerosis	0.000104	0.000219	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—amyotrophic lateral sclerosis	0.000104	0.000219	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000103	0.000218	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000103	0.000218	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000103	0.000218	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.74e-05	0.000206	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.5e-05	0.000201	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.37e-05	0.000198	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	9.25e-05	0.000196	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOE—amyotrophic lateral sclerosis	8.45e-05	0.000179	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APOE—amyotrophic lateral sclerosis	8.45e-05	0.000179	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOE—amyotrophic lateral sclerosis	8.45e-05	0.000179	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP9—amyotrophic lateral sclerosis	8.23e-05	0.000174	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP9—amyotrophic lateral sclerosis	8.23e-05	0.000174	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOE—amyotrophic lateral sclerosis	8.01e-05	0.00017	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	7.39e-05	0.000157	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	7.39e-05	0.000157	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	7.28e-05	0.000154	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	7.28e-05	0.000154	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	6.66e-05	0.000141	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.19e-05	0.000131	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	5.82e-05	0.000123	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.79e-05	0.000123	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.79e-05	0.000123	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.79e-05	0.000123	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.49e-05	0.000116	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	5.26e-05	0.000111	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	3.99e-05	8.44e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	3.68e-05	7.79e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.02e-05	6.4e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.62e-05	3.44e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.49e-05	3.16e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	1.23e-05	2.6e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.41e-06	1.78e-05	CbGpPWpGaD
